MARKET

BLRX

BLRX

Biolinerx
NASDAQ
2.920
-0.040
-1.35%
After Hours: 2.990 +0.07 +2.40% 16:50 04/01 EDT
OPEN
3.060
PREV CLOSE
2.960
HIGH
3.130
LOW
2.850
VOLUME
68.72K
TURNOVER
63.75K
52 WEEK HIGH
44.00
52 WEEK LOW
2.850
MARKET CAP
10.87M
P/E (TTM)
-0.0068
1D
5D
1M
3M
1Y
5Y
1D
BioLineRx Ltd. Reports 2024 Financial Results and Strategic Progress
TipRanks · 17h ago
BioLineRx Earnings Call: Strategic Shifts and Growth
TipRanks · 21h ago
BioLine RX Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 1d ago
BioLine RX Price Target Raised to $26.00/Share From $9.00 by HC Wainwright & Co.
Dow Jones · 1d ago
HC Wainwright & Co. Maintains Buy on BioLine Rx, Raises Price Target to $26
Benzinga · 1d ago
BIOLINE RX LTD <BLRX.O>: H.C. WAINWRIGHT ADJUSTS TARGET PRICE TO $26 FROM $9 TO REFLECT 1-FOR-40 REVERSE STOCK SPLIT
Reuters · 1d ago
BioLineRx price target adjusted to $26 at H.C. Wainwright after reverse split
TipRanks · 1d ago
BioLineRx Reports Strong 2024 Financial Results and Strategic Advancements
TipRanks · 1d ago
More
About BLRX
More
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Recently
Symbol
Price
%Change

Webull offers BioLine RX Ltd - ADR stock information, including NASDAQ: BLRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLRX stock methods without spending real money on the virtual paper trading platform.